Skip to Content

Join the 'Neoral' group to help and get support from people like you.

Neoral News

A Reminder That Meds and Grapefruit Don't Always Mix

Posted 23 Jul 2017 by Drugs.com

SUNDAY, July 23, 2017 – If you like grapefruit juice, you need to be aware that it can affect the way some medications work, especially those used to treat high blood pressure or an irregular heart rhythm. That's the message from the U.S. Food and Drug Administration. The FDA requires some prescription and over-the-counter drugs taken by mouth to include warnings against drinking grapefruit ...

New Kidney Transplant Drug Cuts Risk of Earlier Death: Study

Posted 28 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 27, 2016 – A newer drug used for preventing organ rejection might improve the long-term outlook for kidney transplant recipients, a new study finds. Over seven years, patients given the drug belatacept (brand name: Nulojix) were 43 percent less likely to die or see their donor kidney fail compared to patients given an older drug called cyclosporine. Experts said the findings ...

More New Drugs a Bad Fit With Grapefruit, Study Finds

Posted 26 Nov 2012 by Drugs.com

MONDAY, Nov. 26 – Because of new chemical formulations, prescription drugs that interact badly with grapefruit have more than doubled in number since 2008, yet many doctors seem unaware of this, Canadian researchers report. "The number of drugs on the market with the potential to produce serious adverse and in many cases life-threatening effects when combined with grapefruit has markedly ...

Newer Psoriasis Drugs May Lower Heart Attack Risk for Patients

Posted 20 Aug 2012 by Drugs.com

MONDAY, Aug. 20 – People with psoriasis who take a new class of drugs known as tumor necrosis factor (TNF) inhibitors may be at a lower risk for heart attack than their counterparts who only use topical medications to treat this inflammatory skin condition, a new study shows. And patients taking older systemic medicines and phototherapy may also have a reduced heart attack risk compared to those ...

Organ-Rejection Drug Linked to Higher Cancer Risk After Liver Transplant

Posted 28 Jun 2010 by Drugs.com

MONDAY, June 28 – Cyclosporine, a drug commonly used to prevent organ rejection following a transplant, has been linked to a significantly increased risk of developing cancer after liver transplant, new Dutch research reveals. The study was done in part to examine what role drugs that suppress the immune system might play in the development of cancer in liver transplant patients, whose long-term ...

Ask a Question

Further Information

Related Condition Support Groups

Psoriasis, Crohn's Disease, Ulcerative Colitis, Idiopathic (Immune) Thrombocytopenic Purpura, Inflammatory Bowel Disease, Organ Transplant - Rejection Prophylaxis, Organ Transplant - Rejection Reversal, Rheumatoid Arthritis

Neoral Patient Information at Drugs.com